372102-79-9

Upstream product

• 372102-35-7 C₃₃H₂₈BrNO₆S 
• 680-15-9 2,2-difluoro-2-(fluorosulfonyl)acetate 
• 372102-30-2 N-(3-{(E)-3-[4-(benzyloxy)-3-bromophenyl]-2-propenoyl}-2-hydroxy-5-methylphenyl)acetamide 
• 372102-31-3 N-{2-[4-(benzyloxy)-3-bromophenyl]-3-hydroxy-6-methyl-4-oxo-4H-chromen-8-yl}acetamide 
• 372102-33-5 N-{3-(benzyloxy)-2-[4-(benzyloxy)-3-bromophenyl]-6-methyl-4-oxo-4H-chromen-8-yl}acetamide 
• 372102-34-6 8-amino-3(benzyloxy)-2-[4-(benzyloxy)-3-bromophenyl]-6-methyl-4H-chromen-4-one 
• 69455-12-5 4-benzyloxy-3-bromobenzaldehyde 
• 103797-05-3 N-(3-acetyl-2-hydroxy-5-methyl-phenyl)-acetamide 

Relevant academic research and scientific papers

3-Hydroxychromones as cyclin-dependent kinase inhibitors: Synthesis and biological evaluation

A novel series of 3-hydroxychromones were prepared and found to be CDK inhibitors. Isothiazolidine 1,1-dioxide analogues showed potent CDK1 and CDK2 inhibitory activities and inhibited proliferation of EJ, HCT116, SW620, and MDAMB468 cancer cells.